Delivery Order SPE2DB20D1004-SPE2DB25FNFGH

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB24D1006|SPE2DB25FCDXF, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $14,177.66 Firm Fixed Price contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with an ID of SPE2DB24D3015|SPE2DB25FFXTK, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,324.82, for the purchase of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN41E, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,586.08 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.42 firm fixed price delivery order is for the provision of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award SPE2DB22D2206 | SPE2DB25FFR00 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML. The $7,728.76 Firm Fixed Price contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,019.25, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a...
This federal contract award, with ID SPE2DB20D3505|SPE2DB24FU2P2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.90 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has a completion date of June 3, 2024 and was awarded on May 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,515.03 firm-fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML. The award, valued at $3,126.41, has a firm fixed price and an ultimate completion date of August 19, 2024. The contract is not set aside. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,765.47 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNFGH
    Delivery Order

This federal contract award, with the ID SPE2DB20D1004|SPE2DB25FNFGH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,133.81 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.

Generated 6/2/25, 10:02 AM